Trisalus Life Sciences Inc (TLSI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 2,984 | 8,475 | 3,923 | 0 | 0 |
| Cost of Goods | 662 | 1,557 | 701 | N/A | N/A |
| Gross Profit | 2,322 | 6,918 | 3,222 | N/A | N/A |
| Operating Expenses | 13,105 | 34,845 | 12,034 | 288 | 670 |
| Operating Income | -10,121 | -27,370 | -8,111 | -288 | -670 |
| Interest Expense | 5 | 0 | 0 | 0 | 0 |
| Other Income | 1,853 | -16,966 | 18 | 2,703 | 3,507 |
| Pre-tax Income | -8,273 | -44,336 | -8,093 | 2,414 | 2,837 |
| Income Tax | -5 | -19 | N/A | 28 | 0 |
| Net Income Continuous | -8,268 | -44,317 | -8,093 | 2,386 | 2,837 |
| Net Income | $-8,268 | $-44,317 | $-8,093 | $2,386 | $2,837 |
| EPS Basic Total Ops | -0.57 | -135.77 | -25.95 | 0.08 | 0.09 |
| EPS Basic Continuous Ops | -0.51 | -127.10 | -25.95 | 0.38 | 0.45 |
| EPS Diluted Total Ops | -0.57 | -135.77 | -25.95 | 0.08 | 0.09 |
| EPS Diluted Continuous Ops | -0.51 | -127.10 | -25.95 | 0.38 | 0.45 |
| EBITDA(a) | $-9,937 | $-27,424 | $-8,111 | $-288 | $-670 |